Yaya Yu

1.3k total citations · 1 hit paper
25 papers, 871 citations indexed

About

Yaya Yu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yaya Yu has authored 25 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Yaya Yu's work include Cancer-related molecular mechanisms research (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Yaya Yu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Yaya Yu collaborates with scholars based in China and United States. Yaya Yu's co-authors include Swei Sunny Hann, Shunqin Long, Xiaojuan Li, Yun Chen, Wanyin Wu, Sumei Wang, Ling Han, Tang Qing, Shi Yao and Adhip P.N. Majumdar and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Frontiers in Immunology.

In The Last Decade

Yaya Yu

25 papers receiving 868 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers

2022 313 citations Tang Qing, Yun Chen et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Yaya Yu

Since Specialization

Citations

This map shows the geographic impact of Yaya Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaya Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaya Yu more than expected).

Fields of papers citing papers by Yaya Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaya Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaya Yu. The network helps show where Yaya Yu may publish in the future.

Co-authorship network of co-authors of Yaya Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaya Yu. A scholar is included among the top collaborators of Yaya Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaya Yu. Yaya Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aroma compounds with enhanced sweet perception in tea infusions: Screening, characterization, and sweetening mechanism 2025 ·Journal of Advanced Research ·Yuming Wei, Yaya Yu, Yuanchao Li, Xiaoyu Zhong, Chun Zou, Jingming Ning, Wenjiang Dong, Kegang Wu, (unknown)	3
2	Biocompatible N-carbazoleacetic acid decorated Cu_xO nanoparticles as self-cascading platforms for synergistic single near-infrared triggered phototherapy treating microbial infections 2024 ·Biomaterials Science ·(unknown), (unknown), Shengnan Song, Wenhui Wang, Shan Huang, (unknown), Bo Li, Yaya Yu, Ya‐Mu Xia, Wei‐Wei Gao	4
3	Construction of Mn–N–C nanoparticles with multienzyme-like properties and photothermal performance for the effective treatment of bacterial infections 2023 ·Biomaterials Science ·(unknown), (unknown), Yaya Yu, Shengnan Song, (unknown), (unknown), (unknown), Chunhuan Zhang, Shan Huang, Ya‐Mu Xia, Wei‐Wei Gao	5
4	FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma 2023 ·Journal of Ethnopharmacology ·Qing Tang, (unknown), Shunqin Long, Yaya Yu, (unknown), (unknown), (unknown), Xi Wang, Fang Fang, Ling Han, Wanyin Wu, Sumei Wang	7
5	BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells 2023 ·BMC Cancer ·Yaya Yu, (unknown), (unknown), (unknown), Lina Ding, Qing Tang, Yihan He, (unknown), (unknown), Yan-juan Zhu, Haibo Zhang	9
6	Lung cancer organoids, a promising model still with long way to go 2022 ·Critical Reviews in Oncology/Hematology ·(unknown), Yan-juan Zhu, Rui Zhou, Yaya Yu, (unknown), Haibo Zhang	22
7	Bone metastasis attenuates efficacy of immune checkpoint inhibitors and displays “cold” immune characteristics in Non-small cell lung cancer 2022 ·Lung Cancer ·Yan-juan Zhu, (unknown), Rui Zhou, (unknown), (unknown), (unknown), (unknown), Yi‐Hong Liu, Lirong Liu, Yong Li, Yaya Yu, Haibo Zhang	25
8	The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers breakdown → 2022 ·Frontiers in Immunology ·Tang Qing, Yun Chen, Xiaojuan Li, Shunqin Long, Shi Yao, Yaya Yu, Wanyin Wu, Ling Han, Sumei Wang	313
9	The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers 2022 ·Biomarker Research ·Yaya Yu, Yan-juan Zhu, (unknown), (unknown), (unknown), Yi‐Hong Liu, Qing Tang, Haibo Zhang	19
10	Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models 2021 ·Evidence-based Complementary and Alternative Medicine ·Yaya Yu, Yan-juan Zhu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Haibo Zhang	5
11	Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials 2021 ·BMC Cancer ·(unknown), Yi‐Hong Liu, (unknown), Yufeng Liu, (unknown), Yan-juan Zhu, (unknown), (unknown), (unknown), Yaya Yu, Rui Zhou, Haibo Zhang	20
12	SMRT sequencing of the full-length transcriptome of the white-backed planthopper Sogatella furcifera 2020 ·PeerJ ·Jing Chen, Yaya Yu, Kui Dong Kang, (unknown)	11
13	Comparing value of transesophageal echocardiography, dual-source CT and left atrial appendage angiography in selection of left atrial appendage occluder size 2019 ·(unknown), (unknown), (unknown), Yaya Yu, Wei Zheng, Xiaorong Li, Hongping Wu, Bing Yang, Xiujuan Zhou	1
14	<p>Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer</p> 2019 ·OncoTargets and Therapy ·Yaya Yu, Swei Sunny Hann	48
15	The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells 2019 ·Frontiers in Oncology ·Zheng Liu, (unknown), Xiaojuan Tang, Qing Tang, (unknown), Yaya Yu, Fang Zheng, Jingjing Wu, Xiaobo Yang, Wei Wang, Swei Sunny Hann	24
16	<p>The emerging roles of PIWI-interacting RNA in human cancers</p> 2019 ·Cancer Management and Research ·Yaya Yu, Jing Xiao, Swei Sunny Hann	51
17	[Expert consensus on the diagnosis and treatment of cryptococcal meningitis]. 2018 ·PubMed ·(unknown), (unknown), Liping Zhu, (unknown), (unknown), Yaya Yu, Zhuoming Zhou, (unknown), (unknown), (unknown), (unknown), (unknown), Hao Wu, Yun Xu, Hongzhou Lu, (unknown)	25
18	Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus 2018 ·Nature Communications ·Jiankai Liang, Li Guo, Kai Li, Xiao Xiao, Wenbo Zhu, Xiaoke Zheng, Jun Hu, Haipeng Zhang, Jing Cai, Yaya Yu, Yaqian Tan, Chuntao Li, Xincheng Liu, (unknown), Ying Liu, Pengxin Qiu, Xingwen Su, (unknown), Yuan Lin, Guangmei Yan	24
19	Yangzheng Sanjie decoction regulates proliferation and apoptosis of gastric cancer cells by enhancing let-7a expression 2017 ·World Journal of Gastroenterology ·(unknown), Yaya Yu, (unknown), Jingli Zhu, Lina Luo, Wanqun Chen, Ling Hu, (unknown)	12
20	MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF R2) in colon cancer cells 2011 ·Carcinogenesis ·Yaya Yu, Shailender S. Kanwar, Bhaumik B. Patel, Philmo Oh, Jaya Nautiyal, F. H. Sarkar, Adhip P.N. Majumdar	219

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact